News

The UK CARDIO-IMID Partnership is pleased to announce the opening of our Travel Fellowship Scheme. Applications for the 2025 cohort will be open until 11th July 2025 for placements taking place between 31st July – 31st December 2025. This programme supports the Workstream 1 - Education and Network arm of the Partnership and represents an […]

Cardio-Rheumatology: Emerging sub-speciality interest session The UK CARDIO-IMID Partnership had strong representation at this year's British Society for Rheumatology Conference (BSR) on April 28-30th in Manchester, with many investigators, academics and early-career researchers in attendance. A highlight of the conference was our Cardio-Rheumatology: Emerging sub-speciality interest session on 30th April, presented by our executive steering […]

In this review article published in Rheumatology, Dr Marta Peverelli and Dr Jason Tarkin from the UK CARDIO-IMID PET-CT team in Cambridge explore several of the most promising emerging PET radionucleotide tracers for imaging vascular inflammation.

In this case-study, published by the National Institute for Health and Care Research (NIHR), the aims and objectives of the UK CARDIO-IMID Partnership are outlined, and context provided regarding how the Partnership sits within the established infrastructure of the NIHR Biomedical Research Centres and British Heart Foundation Centres of Research Excellence.

In this letter published in Rheumatology, authored by our chief investigator Professor Maya H. Buch and UK CARDIO-IMID Partnership members from Manchester, we present the results of a UK-wide survey of 85 rheumatology clinicians seeking to understand how cardiovascular risk assessment in patients with IMIDs is approached in the hospital setting, and perspectives on cardiovascular imaging.

We are pleased to announce release of the first publication from the UK CARDIO-IMID Partnership. In this Nature Reviews Rheumatology article, authored by our core investigators, we summarise current concepts on the potentially targetable inflammatory mechanisms of cardiovascular pathology in rheumatic IMIDs and discuss how these concepts can be considered for the diagnosis and management of cardiovascular involvement across rheumatic IMIDs, with an emphasis on the potential of cardiovascular imaging for risk stratification, early detection and prognostication.